Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Accumulated Depreciation Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Accumulated Depreciation
-$2.4m
CAGR 3-Years
-50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bright Minds Biosciences Inc
CNSX:DRUG
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Accumulated Depreciation
-$7.3m
CAGR 3-Years
-54%
CAGR 5-Years
-71%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Accumulated Depreciation
-CA$2.5m
CAGR 3-Years
-1%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Accumulated Depreciation?
Accumulated Depreciation
-2.4m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Accumulated Depreciation amounts to -2.4m USD.

What is Aurinia Pharmaceuticals Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 3Y
-50%

Over the last year, the Accumulated Depreciation growth was -32%. The average annual Accumulated Depreciation growth rates for Aurinia Pharmaceuticals Inc have been -50% over the past three years .

Back to Top